Study 2 Sample Clauses

Study 2. 1 3 Klinické hodnocení The clinical study known as A Multicenter, Randomized, Double-blind, Xxxxxxx-xxxxxxxxxx Xxxxx 0
Sample 1Sample 2
AutoNDA by SimpleDocs
Study 2. Teachers We can conclude from the general questionnaire that teachers nowadays are familiar with active learning and that they try to make their class more interactive (Table 14). These two questions are significantly positively correlated, with a moderate correlation of 0,592. A lot of different methods are being used when teachers incorporate active learning in their class. For example: visual based instruction (kahoot, quizlet, PowerPoint, …), debates, different sorts of quizzes, groupwork, movies, …. Kahoot seemed to be a popular method, because it was mentioned 12 times, especially given the fact that there were only 34 participants. Quizzes were also frequently used, only 6 respondents answered that they never use quizzes. The usage rate of quizzes fluctuated between one and more than 5 times during one semester for one course. Table 15 shows that 91,18% of our respondents made use of PowerPoint to make their class more active. When we asked about how many times they made use of PowerPoint while they teach, 28,13% answered that they used PowerPoint weekly and 50,00% said they made use of PowerPoint during each class. Table 14 – Descriptive Statistics Teachers and One-Sample T-Test with Test Value = 3 General questions N Mean Maximu m Minimu m SD T p-value (one- sided) Question 1 34 3,74 5 1 1,024 4,186 0,000 Question 2 34 3,85 5 1 0,784 6,347 0,000 Table 15 – Results General Questionnaire Teachers 1 = Never 2 = Less than once per month 3 = 1 to 3 times per month 4 = Weekly 5 = Each class General questions
Sample 1
Study 2. Non-Treatment Seeking Sample Results derived from comparisons between anxious youth and the Matched sample were largely consistent with those from the full sample, thus details are reported in supplementary materials.
Sample 1
Study 2. 1 3 Klinické hodnocení The clinical study known as A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3
Sample 1
Study 2. Question 12 from study 2 provided some ideas to make the games even better. These ideas are listed in Table 21. Table 21 – Recommendations on the Games Bingo Jeopardy Connect 4 Comments # times mentioned Comments # times mentioned Comments # times mentioned Formulation of questions (only one answer should be possible in order to avoid any discussion with pupils) 4 Formulation of questions (only one answer should be possible in order to avoid any discussion with pupils) 3 Less applicable in large groups 5 Time pressure 5 More variation in the different kinds of questions 2 Preparation for an examination / temporary evaluation 2 Some pupils might lose their motivation in the second round 4 An equal amount of questions for each team 5 Time pressure 1 Pupils will shout the answers or cheat 2 Pupils have to think about posing the right question (perceived as more difficult, good exercise) 2 In regards to Bingo, many teachers recommended to include an extra round of questions during the second round with the same numbers in order to avoid a lack of motivation for the students who were not able to answer every question right. Another solution for this problem was to let students shout ‘bingo’ after obtaining a full row instead of the whole card. We think that the teachers had a valid point and we would take the second solution into consideration. Timing also seemed to be an issue for some teachers: they found that the time was not used efficiently because it took a lot of time to spin the wheel. This problem might be solved by using a bowl with numbers in it or to call out random numbers. There was even a teacher that already used Bingo in their class. Another teacher came up with the idea to include a score that would reflect the level of the individual pupils, this might be a good idea especially when the teacher wants to find out who is struggling and which parts of the material are perceived to be more difficult. One teacher found Xxxxx ideal for the last class before a recess and another one suggested to let pupils play the game at home. In regard to the Jeopardy game, the teachers also pointed out the importance of the formulation of questions. It is important that there is only one possible answer in order to avoid any discussion with pupils. We on the other hand think that the different answers of the students show that they have gained insight in the material, which is exactly one of our purposes that were achieved for both studies. Furthermore, Xxxxxxx ...
Sample 1

Related to Study 2

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Study Area The study area focused on the Bulk Power System in South-Eastern New York between Albany and New York City, and voltages underlying systems at 115 kV and above in the lower Xxxxxx Valley (Zones G, H & I). In the PSS™E power flow base case provided by NYISO, facilities rated at 115 kV and above in PSS™E designated areas 6 through 11 are monitored in the study. These areas are: • Capital District • Xxxxxx • Millwood • Xxxxxxxxx • Con Ed • Long Island

  • Study Design This includes a discussion of the evaluation design employed including research questions and hypotheses; type of study design; impacted populations and stakeholders; data sources; and data collection; analysis techniques, including controls or adjustments for differences in comparison groups, controls for other interventions in the State and any sensitivity analyses, and limitations of the study.

  • The Study 2.1The parties must comply with, and conduct the Study in accordance with, the Protocol and any conditions of the Reviewing HREC. In addition the parties must comply with the following, as applicable:

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Research, Science and Technology Cooperation 1. The aims of cooperation in research, science and technology, carried out in the mutual interest of the Parties and in compliance with their policies, will be: (a) to build on existing agreements already in place for cooperation on research, science and technology; (b) to encourage, where appropriate, government agencies, research institutions, universities, private companies and other research organizations in the Parties to conclude direct arrangements in support of cooperative activities, programs or projects within the framework of this Agreement, specially related to trade and commerce; and (c) to focus cooperative activities towards sectors where mutual and complementary interests exist, with special emphasis on information and communication technologies and software development to facilitate trade between the Parties. 2. The Parties will encourage and facilitate, as appropriate, the following activities including, but not limited to:

  • Phase 2 Phase 2 is expected to consist of Member Nodes and a select number of Nodes operated by non-Members. The non-Member Nodes will be required to comply with Node hosting terms as set forth by the Council, which may be amended from time to time (the “General Node Terms”).

  • System Impact Study An assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!